Clomiphene Citrate versus Letrozole in Men with Infertility

Effects of Clomiphene Citrate versus Letrozole on Semen Count and Motility in Men with Oligoasthenozoospermia in Osogbo: A Randomized Study.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201910906791073

Enrollment

140

Registered

2019-10-21

Start date

2019-10-20

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-male

Interventions

alternate day 50mg of clomiphene citrate will be given for 3 months

LETROZOLE

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Men with abnormal semen counts Men with abnormal semen motility

Exclusion criteria

Exclusion criteria: Men with Azoospermia Men with normal semen count Non consenting men

Design outcomes

Primary

Measure	Time frame
IMPROVEMENT IN SEMEN COUNT AND MOTILITY FOLLOWING ADMINISTRATION OF CLOMIPHENE CITRATE AND LETROZOLE IN MEN WITH OLIGOASTHENOZOOSPERMIA	—

Secondary

Measure	Time frame
POSITIVE PREGNANCY TEST IN SPOUSE AFTER TREATMENT	—

Countries

Nigeria

Contacts

Public ContactAKINBOWALE BUSAYO

cheif nursing officer

busayoakinbowale2@gmail.com08034125952

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026